Nonproductive human immunodeficiency virus type 1 infection in nucleoside-treated G0 lymphocytes

Journal of Virology

Volumn 73, Issue 8, 1999, Pages 6526-6532

  Korin, Yael D ^a   Zack, Jerome A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOSIDE; VIRUS VECTOR;

ANTIGEN PRESENTING CELL; ARTICLE; CELL CYCLE G0 PHASE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; REPORTER GENE; REVERSE TRANSCRIPTION; TARGET CELL; VIRUS ACTIVATION; VIRUS EXPRESSION; VIRUS REPLICATION;

EID: 0032795284     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.8.6526-6532.1999     Document Type: Article

References (29)

1. Chen, I. S., and H. M. Temin. 1982. Establishment of infection by spleen necrosis virus: inhibition in stationary cells and the role of secondary infection. J. Virol. 41:183-191.
2. Cohen, A., J. Barankiewicz, H. M. Lederman, and E. W. Gelfand. 1983. Purine and pyrimidine metabolism in human T lymphocytes. Regulation of deoxyribonucleotide metabolism. J. Biol. Chem. 258:12334-12340.
3. Eriksson, S., L. Thelander, and M. Akerman. 1979. Allosteric regulation of calf thymus ribonucleoside diphosphate reductase. Biochemistry 18:2948-2952.
4. Gao, W. Y., R. Agbaria, J. S. Driscoll, and H. Mitsuya. 1994. Divergent anti-human immunodeficiency virus activity and anabolic phosphorylation of 2′,3′-dideoxynucleoside analogs in resting and activated human cells. J. Biol. Chem. 269:12633-12638.
5. Gao, W. Y., A. Cara, R. C. Gallo, and F. Lori. 1993. Low levels of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit human immunodeficiency virus type 1 replication. Proc. Natl. Acad. Sci. USA 90:8925-8928.
6. Gao, W. Y., T. Shirasaka, D. G. Johns, S. Broder, and H. Mitsuya. 1993. Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells. J. Clin. Investig. 91:2326-2333.
7. Goulaouic, H., F. Subra, J. F. Mouscadet, S. Carteau, and C. Auclair. 1994. Exogenous nucleosides promote the completion of MoMLV DNA synthesis in GO-arrested Balb c/3T3 fibroblasts. Virology 200:87-97.
8. Heinzinger, N., L. Baca-Regen, M. Stevenson, and H. E. Gendelman. 1995. Efficient synthesis of viral nucleic acids following monocyte infection by HIV-1. Virology 206:731-735.
9. Jamieson, B. D., and J. A. Zack. 1998. In vivo pathogenesis of a human immunodeficiency virus type 1 reporter virus. J. Virol. 72:6520-6526.
10. Kinoshita, S. 1998. Host control of HIV-1 parasitism in T cells by the nuclear factor of activated T cells. Cell 95:595-604.
11. Korin, Y. D., and J. A. Zack. 1998. Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells. J. Virol. 72:3161-3168.
12. Li, G., M. Simm, M. J. Potash, and D. J. Volsky. 1993. Human immunodeficiency virus type 1 DNA synthesis, integration, and efficient viral replication in growth-arrested T cells. J. Virol. 67:3969-3977.
13. Lori, F., A. Malykh, A. Cara, D. Sun, J. N. Weinstein, J. Lisziewicz, and R. C. Gallo. 1994. Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication. Science 266:801-805.
14. Marinen, Y. M., D. de Korte, W. A. Haverkort, E. J. den Breejen, A. H. van Gennip, and D. Roos. 1989. Studies on the incorporation of precursors into purine and pyrimidine nucleotides via 'de novo' and 'salvage' pathways in normal lymphocytes and lymphoblastic cell-line cells. Biochim. Biophys. Acta 1012:148-155.
15. Mejerhans, A., J. P. Vartanian, C. Hultgren, U. Plikat, A. Karlsson, L. Wang, S. Eriksson, and S. Wain-Hobson. 1994. Restriction and enhancement of human immunodeficiency virus type 1 replication by modulation of intracellular deoxynucleoside triphosphate pools. J. Virol. 68:535-540.
16. O'Brien, W. A., A. Namazi, H. Kalhor, S. H. Mao, J. A. Zack, and I. S. Chen. 1994. Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors. J. Virol. 68:1258-1263.
17. Shirasaka, T., S. Chokekijchai, A. Yamada, G. Gosselin, J. L. Imbach, and H. Mitsuya. 1995. Comparative analysis of anti-human immunodeficiency virus type 1 activities of dideoxynucleoside analogs in resting and activated peripheral blood mononuclear cells. Antimicrob. Agents Chemother. 39: 2555-2559.
18. Spaapen, L. J., J. G. Scharenberg, B. J. Zegers, G. T. Rijkers, M. Duran, and S. K. Wadman. 1986. Intracellular purine and pyrimidine nucleotide pools of human T and B lymphocytes. Adv. Exp. Med. Biol. 195A:567-573.
19. Stevenson, M., B. Brichacek, N. Heinzinger, S. Swindells, S. Pirruccello, E. Janoff, and M. Emerman. 1995. Molecular basis of cell cycle dependent HIV-1 replication. Implications for control of virus burden. Adv. Exp. Med. Biol. 374:33-45.
20. Stevenson, M., T. L. Stanwick, M. P. Dempsey, and C. A. Lamonica. 1990. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J. 9:1551-1560.
21. + T cells are infectible by human immunodeficiency virus but do not release virus after activation. J. Virol. 69:5659-5665.
22. Thelander, L., and P. Reichard. 1979. Reduction of ribonucleotides. Annu. Rev. Biochem. 48:133-158.
23. Toba, K., E. F. Winton, T. Koike, and A. Shibata. 1995. Simultaneous three-color analysis of the surface phenotype and DNA-RNA quantitation using 7-amino-actinomycin D and pyronin Y. J. Immunol. Methods 182:193-207.
24. Varmus, H. E., T. Padgett, S. Heasley, G. Simon, and J. M. Bishop. 1977. Cellular functions are required for the synthesis and integration of avian sarcoma virus-specific DNA. Cell 11:307-319.
25. Zack, J. A. 1995. The role of the cell cycle in HIV-1 infection. Adv. Exp. Med. Biol. 374:27-31.
26. Zack, J. A., S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip, and I. S. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213-222.
27. Zack, J. A., A. M. Haislip, P. Krogstad, and I. S. Chen. 1992. Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle. J. Virol. 66:1717-1725.
28. Zhang, H., G. Dornadula, and R. J. Pomerantz. 1996. Endogenous reverse transcription of human immunodeficiency virus type 1 in physiological microenvironments: an important stage for viral infection of nondividing cells. J. Virol. 70:2809-2824.
29. Zhang, H., Y. Zhang, T. P. Spicer, L. Z. Abbott, M. Abbott, and B. J. Poiesz. 1993. Reverse transcription takes place within extracellular HIV-1 virions: potential biological significance. AIDS Res. Hum. Retroviruses 9:1287-1296.